Salmeterol versus theophylline in the treatment of asthma

Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
S J PollardA Emmett

Abstract

Although theophylline is recommended by current guidelines for the management of asthma in patients with persistent symptoms, theophylline has a narrow therapeutic index, requiring individual dose titration and regular monitoring of serum theophylline concentrations to avoid adverse effects. To compare the inhaled long-acting bronchodilator, salmeterol, with the oral bronchodilator, theophylline, in the maintenance treatment of asthma. In two multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group studies, patients received salmeterol aerosol 42 micrograms, extended-release theophylline capsules, or placebo twice daily for 12 weeks. Of 638 adult and adolescent patients with moderate asthma who entered the prebaseline theophylline titration period, 154 were withdrawn prior to randomization (71 due to theophylline-related adverse effects); 484 patients comprised the intent-to-treat population. The mean serum theophylline concentration measured approximately seven hours postdose during the titration period in the theophylline group was 12.7 mg/L (70 mumol/L). The same dose during the treatment period resulted in a mean serum theophylline concentration between 7.6 to 7.9 mg/L (42-44 mumol/L) when mea...Continue Reading

References

Jan 1, 1992·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·W W StormsC W Zwillich
Nov 12, 1992·The New England Journal of Medicine·D S PearlmanS W Yancey
Jun 1, 1986·The Journal of Allergy and Clinical Immunology·H S Nelson
Mar 1, 1984·British Journal of Clinical Pharmacology·P D DaviesI A Campbell
Jan 1, 1983·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·R L WilliamsA Bostrom

❮ Previous
Next ❯

Citations

Jun 1, 2000·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
Feb 25, 1998·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·R A Nathan
Mar 27, 2001·Family Practice·M EcclesUNKNOWN North of England Asthma Guideline Development Group
May 31, 2001·The Western Journal of Medicine·H Kalister
Jun 5, 2003·Postgraduate Medical Journal·R H GreenA J Wardlaw
Apr 29, 2005·Journal of Women's Health·Scott L Osur
Dec 8, 2009·American Journal of Obstetrics and Gynecology·Frank R WitterSusan L Connors
Jul 12, 2003·Respiratory Medicine·G LiccardiG Passalacqua
Sep 8, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Milind P SovaniAnne E Tattersfield
Jul 23, 2008·The Cochrane Database of Systematic Reviews·Christopher J Cates, Matthew J Cates
Jul 20, 2007·The Cochrane Database of Systematic Reviews·A K H TeeL B Irving
Jan 27, 2006·The Cochrane Database of Systematic Reviews·P SeddonT J Lasserson
Apr 16, 2010·The Cochrane Database of Systematic Reviews·Francine M DucharmeToby J Lasserson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

The Journal of Allergy and Clinical Immunology
M SchatzD Petitti
American Journal of Obstetrics and Gynecology
J H PerlowM Porto
© 2021 Meta ULC. All rights reserved